EDTA (Ethylenediaminetetraacetic acid) is a chelating agent that binds heavy metals including: arsenic, calcium, and lead.* EDTA chelation therapy is approved by the U.S. Food and Drug Administration (FDA) as a treatment for lead and heavy metal poisoning. It is also used as an emergency treatment for hypercalcemia (excessive calcium levels) and the control of ventricular arrhythmias (abnormal heart rhythms) associated with digitalis toxicity.
EDTA chelation therapy may decrease levels of certain vitamins and minerals in the body, including vitamin C, magnesium, iron, and calcium. For this reason mineral supplementation is required while using this product. EDTA is suggested to be able to remove calcium plaque associated with heart disease, although more studies are needed to support this claim.* Oral Liposomal EDTA is convenient and effective, and has excellent results compared with IV EDTA.
New Production Technology Features:
Made with injectable grade Phosphatidyl Choline, purified from soy lecithin. Does not contain soy proteins normally associated with soy allergies.
Tightly controlled small sizing, verified by Laser Dynamic Light Scattering on each batch.
Liposome mean size 50-150nm.
Mixes easily in water or juice.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Suggested Use:1 tsp in 4 - 8 ounces of water or juice directly in mouth, hold for 30 seconds before swallowing. Best on empty stomach at least 10 minutes before eating.
Storage:Store in a cool, dry place. Keep out of reach of children.
Contraindications:Mineral supplementation is required while using this product.
